Browse
Submit Data
Databases
API
Help

Dataset Information

17 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Tetrakis(2,6-di-methyl-pyridinium) di-hydrogen deca-vanadate dihydrate.

ABSTRACT: The structure of the title compound, (C7H10N)4[H2V10O28]·2H2O, was solved from a non-merohedrally twinned crystal (ratio of twin components ?0.6:0.4). The asymmetric unit consists of one-half deca-vanadate anion (the other half completed by inversion symmetry), two 2,6-di-methyl-pyridinium cations and one water mol-ecule of crystallization. In the crystal, the components are connected by strong N-H?O and O-H?O hydrogen bonds, forming a supra-molecular chain along the b-axis direction. There are weak C-H?O inter-actions between the chains.

SUBMITTER: Rakovsky E

PROVIDER: S-EPMC4051003 | biostudies-literature | 2014 Jun

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Tetrakis(2,6-di-methyl-pyridinium) di-hydrogen deca-vanadate dihydrate.

Rakovský Erik E Krivosudský Lukáš L

Acta crystallographica. Section E, Structure reports online 20140521 Pt 6

The structure of the title compound, (C7H10N)4[H2V10O28]·2H2O, was solved from a non-merohedrally twinned crystal (ratio of twin components ∼0.6:0.4). The asymmetric unit consists of one-half deca-vanadate anion (the other half completed by inversion symmetry), two 2,6-di-methyl-pyridinium cations and one water mol-ecule of crystallization. In the crystal, the components are connected by strong N-H⋯O and O-H⋯O hydrogen bonds, forming a supra-molecular chain along the b-axis direction. There are ...[more]

PMID: 24940209

Similar Datasets

Tris[4,4'-(ethene-1,2-di-yl)dipyridinium] deca-vanadate dihydrate.

Project description:The asymmetric unit of the title compound, (C(12)H(12)N(2))(3)[V(10)O(28)]·2H(2)O, contains one half of a deca-vanadate anion, one and a half trans-1,2-bis-(4-pyridinio)ethene cations and one water mol-ecule. The V(10)O(28) groups are involved in a three-dimensional hydrogen-bonding network through Ow-H?O, N-H?O and C-H?O inter-actions.

| S-EPMC2983728 | biostudies-literature

4,4'-Oxybis(2,6-di-methyl-pyridinium) bis-(tri-fluoro-methane-sulfonate).

Project description:In the asymmetric unit of the title salt, C14H18N2O(2+)·2CF3O3S(-), the components are linked by two N-H?O and one C-H?O hydrogen bonds. The dipyridinium salt demonstrates a skew conformation based upon C-O-C-C torsion angles of 61.5?(3) and 15.1?(4)°. A C-O-C angle of 119.3?(2)° and C-O bond distances of 1.364?(3) and 1.389?(3)?Å are consistent with other dipyridyl ethers. The planes of the pyridyl rings exhibit a twist angle of 67.89?(8)°. One of the tri-fluoro-methane-sulfonate ions shows disorder of the F atoms [in a 0.52?(7):0.48?(7) occupancy ratio] and an O atom [0.64?(8):0.36?(8) occupancy ratio]. In the crystal, the components are linked by C-H?O inter-actions, which form chains along [101].

| S-EPMC3884303 | biostudies-literature

Crystal structure of 4-(di-methyl-amino)-pyridinium 4-amino-benzoate dihydrate.

Project description:In the title hydrated mol-ecular salt, C7H11N2 (+)·C7H6NO2 (-)·2H2O, the cation is protonated at the pyridine N atom and the dihedral angle between the benzene ring and the CO2 (-) group in the anion is 8.5 (2)°. In the crystal, the cation forms an N-H⋯O hydrogen bond to the anion and the anion forms two N-H⋯O hydrogen bonds to adjacent water mol-ecules. Both water mol-ecules form two O-H⋯O hydrogen bonds to carboxyl-ate O atoms. In combination, these hydrogen bonds generate a three-dimensional network and two weak C-H⋯π inter-actions are also observed.

| S-EPMC4331910 | biostudies-literature

Bis(2-amino-6-methyl-pyridinium) tris-(pyridine-2,6-dicarboxyl-ato)zirconate(IV) dihydrate.

Project description:In the title compound, (C(6)H(9)N(2))(2)[Zr(C(7)H(3)NO(4))(3)]·2H(2)O, the Zr(IV) atom is nine-coordinated by three pyridine-2,6-dicarboxyl-ate ligands in a distorted tricapped trigonal-prismatic ZrN(3)O(6) environment. The crystal packing is stabilized by inter-molecular N-H?O and O-H?O hydrogen bonds.

| S-EPMC3052039 | biostudies-literature

3,5-Dicarb-oxy-2,6-dimethyl-pyridinium chloride dihydrate.

Project description:In the title compound, C(9)H(10)NO(4) (+)·Cl(-)·2H(2)O, both the cation and the anion have crystallographic twofold rotation symmetry; in the former, one N and one C atom lie on the rotation axis. In the crystal structure, the ions and water mol-ecules are linked via O-H?O, O-H?Cl and N-H?Cl hydrogen bonds into layers parallel to (101).

| S-EPMC2979551 | biostudies-literature

Hexakis(tetra-aqua-sodium) deca-vanadate(V) dihydrate.

Project description:The title compound, {[Na(H(2)O)(4)](6)[V(10)O(28)]·2H(2)O}(n), crystallized from a H(2)O/THF/CH(3)CN solution (pH ca 6) containing equimolar amounts of NaVO(3) and N-(2-hydroxy-benz-yl)-N-(2-picol-yl)glycine. In the crystal structure, the deca-vanadate [V(10)O(28)](6-) anion ( symmetry) is coordinated, via four terminal oxide ligands of V centres, to two dinuclear [{Na(H(2)O)(3)}(2)(?-H(2)O)(2)](2+) units. Inter-connection of these aquasodium-ion-sandwiched deca-vanadates to chains parallel to [001] is effected by ?-[{Na(H(2)O)(3)}(2)(?-H(2)O)(2)](2+) units, bridging adjacent deca-vanadates via O=V. The structure is consolidated by an extensive network of O-H?O hydrogen bonds.

| S-EPMC2983821 | biostudies-other

Hexakis(2-amino-pyridinium) di-?(6)-oxido-tetra-?(3)-oxido-tetra-deca-?(2)-oxido-octa-oxidodeca-vanadium(V) dihydrate.

Project description:In the title compound, (C(5)H(7)N(2))(6)[V(10)O(28)]·2H(2)O, the [V(10)O(28)](6-) anion is generated by crystallographic inversion symmetry and each of the five vanadium centres adopts a distorted VO(6) octa-hedral geometry. In the crystal structure, a network of N-H?O, N-H?(O,O) and O-H?O hydrogen bonds helps to establish the packing.

| S-EPMC2968550 | biostudies-literature

Bis(2,6-di-methyl-anilinium) di-aqua-bis-(di-hydrogen diphosphato-?(2) O,O')cobaltate(II).

Project description:In the title compound, (C8H12N)2[Co(H2P2O7)2(H2O)2], the Co(2+) ion lies on a crystallographic inversion centre and adopts a slightly distorted octa-hedral CoO6 coordination geometry arising from two chelating diphosphate [H2P2O7](2-) ligands and two trans water mol-ecules. In the crystal, the components are linked by O-H?O, N-H?O and C-H?O hydrogen bonds and weak aromatic ?-? stacking [shortest centroid-centroid separation = 3.778?(2)?Å] inter-actions. (001) layers of alternating organic cations and complex inorganic anions are apparent.

| S-EPMC3998415 | biostudies-literature

Crystal structure of bis-[4-(di-methyl-amino)-pyridinium] aqua-bis-(oxalato)oxidovanadate(IV) dihydrate.

Project description:The title organic-inorganic hybrid salt, (C7H11N2)2[V(C2O4)2O(H2O)]·2H2O, shows a distorted octa-hedral coordination environment for the vanadium(IV) atom in the anion (point group symmetry 2), with four O atoms from two symmetry-related chelating oxalate dianions and two O atoms in trans configuration from a coordinating water mol-ecule and a terminal vanadyl O atom. In the crystal, (001) layers of cations and anions alternate along [001]. The anionic layers are built up by inter-molecular O-H⋯O hydrogen bonds involving the coordinating and solvent water mol-ecules. The cationic layers are linked to the anionic layers via N-H⋯O hydrogen bonds between the pyridinium group and the non-coordinating O atoms of the oxalate group. The 4-(di-methyl-amino)-pyridinium cations are also engaged in π-π stacking with their anti-parallel neighbours [centroid-to-centroid distance = 3.686 (2) Å]. Considering all supra-molecular features, a three-dimensional network structure is accomplished.

| S-EPMC4992925 | biostudies-literature

2-Amino-pyridinium 4-methyl-benzoate dihydrate.

Project description:The crystal structure of the title salt, C(5)H(7)N(2) (+)·C(8)H(7)O(2) (-)·2H(2)O, contains a three-dimensional supra-molecular framework constructed through N-H?O and O-H?O hydrogen bonds.

| S-EPMC2959774 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data